Alkermes plc. Diluted Shares Outstanding (Weighted Average)
Alkermes plc. (ALKS) reported Diluted Shares Outstanding (Weighted Average) of 173.48 million shares for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-07-28.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-07-28
- Alkermes plc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 173.48M shares, a 3.04% increase year-over-year.
- Alkermes plc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 166.20M shares, a 1.51% decline year-over-year.
- Alkermes plc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 169.64M shares, a 2.07% increase year-over-year.
- Alkermes plc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 168.51M shares, a 0.89% increase year-over-year.
- Alkermes plc. weighted average number of shares outstanding, diluted for fiscal 2025 was 168.74M shares, a 0.27% decline from fiscal 2024.
- Alkermes plc. weighted average number of shares outstanding, diluted for fiscal 2024 was 169.20M shares, a 0.31% decline from fiscal 2023.
- Alkermes plc. weighted average number of shares outstanding, diluted for fiscal 2023 was 169.73M shares, a 3.66% increase from fiscal 2022.
- Alkermes plc. weighted average number of shares outstanding, diluted for fiscal 2022 was 163.74M shares, a 0.61% decline from fiscal 2021.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | 173.48M shares 10-Q · filed 2026-07-28 | 166.61M shares 10-Q · filed 2026-07-28 | 169.77M shares derived: average of 3 quarters · filed 2026-07-28 | 169.46M shares derived: average of 4 quarters · filed 2026-07-28 | |
| 2026-03-31 | 166.20M shares 10-Q · filed 2026-05-05 | 167.92M shares derived: average of 2 quarters · filed 2026-05-05 | 168.11M shares derived: average of 3 quarters · filed 2026-05-05 | 168.18M shares derived: average of 4 quarters · filed 2026-07-28 | |
| 2025-12-31 | 169.64M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 169.07M shares derived: average of 2 quarters · filed 2026-02-25 | 168.83M shares derived: average of 3 quarters · filed 2026-07-28 | 168.74M shares 10-K · filed 2026-02-25 | |
| 2025-09-30 | 168.51M shares 10-Q · filed 2025-10-28 | 168.43M shares derived: average of 2 quarters · filed 2026-07-28 | 168.44M shares 10-Q · filed 2025-10-28 | 167.95M shares derived: average of 4 quarters · filed 2026-07-28 | |
| 2025-06-30 | 168.36M shares 10-Q · filed 2026-07-28 | 168.47M shares 10-Q · filed 2026-07-28 | 167.77M shares derived: average of 3 quarters · filed 2026-07-28 | 167.58M shares derived: average of 4 quarters · filed 2026-07-28 | |
| 2025-03-31 | 168.74M shares 10-Q · filed 2026-05-05 | 167.47M shares derived: average of 2 quarters · filed 2026-05-05 | 167.32M shares derived: average of 3 quarters · filed 2026-05-05 | 168.24M shares derived: average of 4 quarters · filed 2026-05-05 | |
| 2024-12-31 | 166.20M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 166.61M shares derived: average of 2 quarters · filed 2026-02-25 | 168.07M shares derived: average of 3 quarters · filed 2026-02-25 | 169.20M shares 10-K · filed 2026-02-25 | |
| 2024-09-30 | 167.03M shares 10-Q · filed 2025-10-28 | 169.00M shares derived: average of 2 quarters · filed 2025-10-28 | 170.20M shares 10-Q · filed 2025-10-28 | 169.24M shares derived: average of 4 quarters · filed 2026-02-25 | |
| 2024-06-30 | 170.98M shares 10-Q · filed 2025-07-29 | 171.96M shares 10-Q · filed 2025-07-29 | 169.98M shares derived: average of 3 quarters · filed 2026-02-25 | 170.46M shares derived: average of 4 quarters · filed 2026-02-25 | |
| 2024-03-31 | 172.98M shares 10-Q · filed 2025-05-01 | 169.48M shares derived: average of 2 quarters · filed 2026-02-25 | 170.29M shares derived: average of 3 quarters · filed 2026-02-25 | 170.60M shares derived: average of 4 quarters · filed 2026-02-25 | |
| 2023-12-31 | 165.98M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | 168.94M shares derived: average of 2 quarters · filed 2026-02-25 | 169.81M shares derived: average of 3 quarters · filed 2026-02-25 | 169.73M shares 10-K · filed 2026-02-25 | |
| 2023-09-30 | 171.90M shares 10-Q · filed 2024-10-24 | 171.73M shares derived: average of 2 quarters · filed 2024-10-24 | 170.98M shares 10-Q · filed 2024-10-24 | 168.22M shares derived: average of 4 quarters · filed 2025-02-12 | |
| 2023-06-30 | 171.55M shares 10-Q · filed 2024-07-24 | 170.75M shares 10-Q · filed 2024-07-24 | 166.99M shares derived: average of 3 quarters · filed 2025-02-12 | 166.32M shares derived: average of 4 quarters · filed 2025-02-12 | |
| 2023-03-31 | 165.09M shares 10-Q · filed 2024-05-01 | 164.72M shares derived: average of 2 quarters · filed 2025-02-12 | 164.57M shares derived: average of 3 quarters · filed 2025-02-12 | 164.39M shares derived: average of 4 quarters · filed 2025-02-12 | |
| 2022-12-31 | 164.34M shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | 164.31M shares derived: average of 2 quarters · filed 2025-02-12 | 164.16M shares derived: average of 3 quarters · filed 2025-02-12 | 163.74M shares 10-K · filed 2025-02-12 | 163.54M shares 10-K · filed 2023-02-16 |
| 2022-09-30 | 164.28M shares 10-Q · filed 2023-10-25 | 164.06M shares derived: average of 2 quarters · filed 2023-10-25 | 163.54M shares 10-Q · filed 2023-10-25 | 166.92M shares derived: average of 4 quarters · filed 2024-02-21 | |
| 2022-06-30 | 163.84M shares 10-Q · filed 2023-07-26 | 163.16M shares 10-Q · filed 2023-07-26 | 167.80M shares derived: average of 3 quarters · filed 2024-02-21 | 166.22M shares derived: average of 4 quarters · filed 2024-02-21 | |
| 2022-03-31 | 162.48M shares 10-Q · filed 2023-04-26 | 169.78M shares derived: average of 2 quarters · filed 2024-02-21 | 167.01M shares derived: average of 3 quarters · filed 2024-02-21 | 166.24M shares derived: average of 4 quarters · filed 2024-02-21 | |
| 2021-12-31 | 177.09M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | 169.27M shares derived: average of 2 quarters · filed 2024-02-21 | 167.49M shares derived: average of 3 quarters · filed 2024-02-21 | 164.75M shares 10-K · filed 2024-02-21 | 160.94M shares 10-K · filed 2023-02-16 |
| 2021-09-30 | 161.46M shares 10-Q · filed 2022-11-02 | 162.70M shares derived: average of 2 quarters · filed 2022-11-02 | 160.64M shares 10-Q · filed 2022-11-02 | ||
| 2021-06-30 | 163.94M shares 10-Q · filed 2022-07-27 | 160.23M shares 10-Q · filed 2022-07-27 | |||
| 2020-12-31 | 158.80M shares 10-K · filed 2023-02-16 | ||||
| 2020-06-30 | 158.90M shares 10-Q · filed 2021-07-28 | 158.50M shares 10-Q · filed 2021-07-28 | |||
| 2015-12-31 | 149.21M shares 10-K · filed 2016-02-25 | ||||
| 2015-06-30 | 148.87M shares 10-Q · filed 2015-07-30 | 148.48M shares 10-Q · filed 2015-07-30 | 147.95M shares derived: average of 3 quarters · filed 2016-02-25 | 147.44M shares derived: average of 4 quarters · filed 2016-02-25 | |
| 2015-03-31 | 148.09M shares 10-Q · filed 2015-04-30 | 147.49M shares derived: average of 2 quarters · filed 2016-02-25 | 146.96M shares derived: average of 3 quarters · filed 2016-02-25 | 148.80M shares derived: average of 4 quarters · filed 2016-02-25 | |
| 2014-12-31 | 146.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | 146.40M shares derived: average of 2 quarters · filed 2016-02-25 | 149.03M shares derived: average of 3 quarters · filed 2016-02-25 | 145.27M shares 10-K · filed 2016-02-25 | |
| 2014-09-30 | 145.90M shares 10-Q · filed 2014-10-29 | 150.10M shares derived: average of 2 quarters · filed 2015-07-30 | 144.73M shares 10-Q · filed 2014-10-29 | 151.93M shares derived: average of 4 quarters · filed 2016-02-25 | |
| 2014-06-30 | 154.30M shares 10-Q · filed 2015-07-30 | 144.14M shares 10-Q · filed 2015-07-30 | 153.94M shares derived: average of 3 quarters · filed 2016-02-25 | 149.48M shares derived: average of 4 quarters · filed 2016-02-25 | |
| 2014-03-31 | 143.36M shares 10-Q · filed 2015-04-30 | 153.76M shares derived: average of 2 quarters · filed 2016-02-25 | 147.88M shares derived: average of 3 quarters · filed 2016-02-25 | 146.75M shares derived: average of 4 quarters · filed 2016-02-25 | |
| 2013-12-31 | 164.17M shares derived: 10-K 9 month − 10-Q 6 month · filed 2016-02-25 | 150.14M shares derived: average of 2 quarters · filed 2016-02-25 | 144.96M shares 10-K · filed 2016-02-25 | 144.01M shares 10-K · filed 2016-02-25 | |
| 2013-09-30 | 136.11M shares 10-Q · filed 2014-10-29 | 135.36M shares 10-Q · filed 2013-10-31 | 143.02M shares 10-Q · filed 2014-10-29 | 139.16M shares derived: average of 4 quarters · filed 2014-10-29 | |
| 2013-06-30 | 143.37M shares 10-Q · filed 2014-07-31 | 141.82M shares 10-Q · filed 2014-07-31 | 140.18M shares derived: average of 3 quarters · filed 2014-07-31 | 137.90M shares derived: average of 4 quarters · filed 2014-07-31 | |
| 2013-03-31 | 139.68M shares 10-Q · filed 2014-04-30 | 138.59M shares derived: average of 2 quarters · filed 2014-04-30 | 136.08M shares derived: average of 3 quarters · filed 2014-04-30 | 137.10M shares 10-K · filed 2015-02-24 | |
| 2012-12-31 | 137.50M shares 10-Q · filed 2013-01-31 | 134.28M shares derived: average of 2 quarters · filed 2013-10-31 | 136.22M shares 10-K · filed 2015-02-24 | 133.35M shares derived: average of 4 quarters · filed 2014-02-27 | |
| 2012-09-30 | 131.07M shares 10-Q · filed 2013-10-31 | 135.59M shares 10-Q · filed 2013-10-31 | 131.96M shares derived: average of 3 quarters · filed 2014-02-27 | 131.39M shares derived: average of 4 quarters · filed 2014-02-27 | |
| 2012-06-30 | 134.94M shares 10-Q · filed 2013-07-25 | 132.41M shares derived: average of 2 quarters · filed 2014-02-27 | 131.50M shares derived: average of 3 quarters · filed 2014-02-27 | 124.24M shares derived: average of 4 quarters · filed 2014-02-27 | |
| 2012-03-31 | 129.87M shares derived: 10-KT 12 month − 10-Q 9 month · filed 2014-02-27 | 129.77M shares derived: average of 2 quarters · filed 2014-02-27 | 120.67M shares derived: average of 3 quarters · filed 2014-02-27 | 114.70M shares 10-KT · filed 2014-02-27 | |
| 2011-12-31 | 129.67M shares 10-Q · filed 2013-01-31 | 116.07M shares derived: average of 2 quarters · filed 2013-01-31 | 109.64M shares 10-Q · filed 2013-01-31 | ||
| 2011-09-30 | 102.47M shares 10-Q · filed 2012-11-01 | 99.58M shares 10-Q · filed 2012-11-01 | |||
| 2011-06-30 | 96.65M shares 10-Q · filed 2012-07-26 | ||||
| 2011-03-31 | 95.61M shares 10-K · filed 2013-05-23 | ||||
| 2010-03-31 | 94.84M shares 10-K · filed 2012-05-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |